Effects of Cinnamon, Cardamom, Saffron, and Ginger Consumption on Markers of Glycemic Control, Lipid Profile, Oxidative Stress, and Inflammation in Type 2 Diabetes Patients
The Review of Diabetic Studies · 2014 · 11 (3-4) · 258-266
DOI: 10.1900/rds.2014.11.258 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Review of Diabetic Studies, 2014. Verfasst von Paria Azimi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Food Security Research Center, Isfahan University of Medical Science, Isfahan, Iran. Hauptthemen laut MEDLINE: Cinnamomum zeylanicum, Crocus, Elettaria, Zingiber officinale. Die Arbeit wurde bisher 171-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Food Security Research Center, Isfahan University of Medical Science, Isfahan, Iran.
Zitieren
APA
Azimi, P., Ghiasvand, R., Feizi, A., Hariri, M., & Abbasi, B. (2014). Effects of Cinnamon, Cardamom, Saffron, and Ginger Consumption on Markers of Glycemic Control, Lipid Profile, Oxidative Stress, and Inflammation in Type 2 Diabetes Patients. The Review of Diabetic Studies, 11(3-4), 258-266. https://doi.org/10.1900/rds.2014.11.258
Vancouver
Azimi P, Ghiasvand R, Feizi A, Hariri M, Abbasi B. Effects of Cinnamon, Cardamom, Saffron, and Ginger Consumption on Markers of Glycemic Control, Lipid Profile, Oxidative Stress, and Inflammation in Type 2 Diabetes Patients. The Review of Diabetic Studies. 2014;11(3-4):258-266. doi:10.1900/rds.2014.11.258
BibTeX
@article{Azimi2014,
author = {Azimi, Paria and Ghiasvand, Reza and Feizi, Awat and Hariri, Mitra and Abbasi, Behnoud},
title = {Effects of Cinnamon, Cardamom, Saffron, and Ginger Consumption on Markers of Glycemic Control, Lipid Profile, Oxidative Stress, and Inflammation in Type 2 Diabetes Patients},
journal = {The Review of Diabetic Studies},
year = {2014},
volume = {11},
number = {3-4},
pages = {258--266},
doi = {10.1900/rds.2014.11.258}
}
EUVIMED